MiNK Therapeutics, Inc. Common Stock (INKT) is a publicly traded Healthcare sector company. As of May 21, 2026, INKT trades at $10.29 with a market cap of $50.02M and a P/E ratio of -3.67. INKT moved +4.15% today. Year to date, INKT is -11.11%; over the trailing twelve months it is +48.60%. Its 52-week range spans $4.56 to $76.00. Analyst consensus is buy with an average price target of $35.00. Rallies surfaces INKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
INKT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. INKT recently traded at $10.29. Market cap is $50.02M. P/E ratio is -3.67. Revenue is $180.25K.
| Metric | Value |
|---|---|
| Price | $10.29 |
| Market Cap | $50.02M |
| P/E Ratio | -3.67 |
| EPS | $-2.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $76.00 |
| 52-Week Low | $4.56 |
| Volume | 9 |
| Avg Volume | 0 |
| Revenue (TTM) | $180.25K |
| Net Income | $-12.49M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $180.25K | $-12.49M | $-2.93 |
| 2024 | $172.57K | $-10.78M | $-2.86 |
| 2023 | $463.26K | $-22.46M | $-0.65 |
| 2022 | $253.32K | $-27.99M | $-0.83 |
1 analysts cover INKT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $35.00.